Navigation Links
Statement of DePuy Orthopaedics, Inc. Regarding Agreement with U.S. Attorney's Office
Date:9/27/2007

WARSAW, Ind., Sept. 27 /PRNewswire/ -- As part of an industry-wide settlement affecting the five major orthopaedics manufacturers, DePuy Orthopaedics, Inc. has entered into an agreement with the United States Attorney's Office that resolves a previously reported government investigation into sales practices in the orthopaedics industry. Terms of the agreement were announced today by the U.S. Attorney's Office, District of New Jersey.

The agreement contains no admission of fault or wrongdoing by DePuy Orthopaedics. Further, the government makes no claim that patient care was impacted by any of the sales practices that were the subject of the investigation.

The agreement signed by DePuy Orthopaedics and the U.S. Attorney's Office notes that the company had "undertaken extensive actions and reforms in furtherance of its commitment to exemplary corporate citizenship" and "voluntarily exhibited a commitment to the continual refinement and improvement of its policies and procedures" with regard to relationships with surgeon consultants.

Surgeon consultants are important sources of innovation for medical technology manufacturers, and they are integral to the training of peers on the use of new technology.

Even before the investigation was announced, DePuy Orthopaedics had implemented processes for the framework and disclosure of relationships with physicians, and supports this agreement and the government's efforts to further positive change throughout the industry.

The terms of the DePuy Orthopaedics agreement call for a deferral of all criminal charges for a period of 18 months, during which an external monitor will be assigned to DePuy Orthopaedics. DePuy Orthopaedics will also pay $84.7 million and will enter into a Corporate Integrity Agreement for a period of five years.

DePuy Orthopaedics believes that the collaboration between government and industry will result in greater transparency in relationships between industry and
'/>"/>

SOURCE DePuy Orthopaedics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Fresh warnings to doctors regarding abortion pill
2. Researchers Present Data Regarding The Efficiency Of Herbs
3. Will anxiety regarding fertility treatment affect the chances of conception?
4. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
5. Indian Government warns Gujarat regarding possibility of bird flu
6. Leeches Provide Clues Regarding The Prevention Of Heart Disease
7. AIDS control requires co-coordinated move regarding safe sexual practices
8. Legal Action against Authority Regarding Outbreak of Legionnaires’ Diseas
9. Mixed Opinion Regarding Common Medical And Engineering Entrance Test
10. Adolescents Influenced By Maternal Attitude Regarding Weight Control
11. Tension between MP And the Cancer Council Head Regarding Screening Test for Male Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... Moravia,s Nanjing-based Service Deliver...ce , Brno, Czech Republic...tion solution provider, is pleased to announce its... 2009, to be held in Nanjing, China, on November 3...Union-based companies that have established and gr...
(Date:11/29/2009)... CA--New connections begin to form between brain c...k, according to a study published this week in Na...ifornia, Santa Cruz, the study involved detailed o...ace in the brain during motor learning. , The re...ch through a slot to get a seed. They observed rap...
(Date:11/29/2009)...aware the sleep disorder boosts urine production, ...Day News) -- People who wake up during the night t...al problem. Sleep apnea, a breathing-related sleep...ggests that nighttime urination, or nocturia, is c...ive sleep apnea, a disorder in which soft tissue i...
(Date:11/28/2009)...HICAGO, Nov. 28 Get ready for a... the clinical routine when Siemens introduces ...ly and Annual Meeting of the Radiological Society ...er 3 at McCormick Place (Booth #825, East Building...o. via , Siemens, new imaging software for mu...
(Date:11/27/2009)...DFORD, Mass., Nov. 27 GS...a supplier of precision technology products and se...l meeting of the Company,s shareholders has been s... location of the meeting will be announced in due ...ived a requisition notice from Stephen Bershad, a ...
Breaking Medicine News(10 mins):Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
...e sex hormone testosterone, which plays a key role...mer's, a progressive brain disorder.// People...arn, make judgments, communicate and carry out dai...ation, as well as delusions or hallucinations. ...
...nologies (LCT) Limited has published evidence outl...rcine islet cells and insulin production in a huma...l transplant. The scientific paper publishe...ion of its encapsulated porcine islets in a human ...
...a-burning women libbers would love to endorse. // ...s, revised edition 2001) by authors Sydney Ross Si...) had come out with claims that wearing a bra thr... interviews of 4,730 women in five major US cities...
...d in their obsession for that ‘bronzed and beautif... trend, opine researchers. // According to a r...Journal of Public Health, the increases in people ...en sunbed use and increased risks of melanoma, as ...
... reduce the number of infants and toddlers develop...y. //The research was carried out by Katherine A. ...’s Hospital, part of Wake Forest University Baptis... and a team of researchers followed about 27,000 c...
... by NHS dentists last year, has left Health Trusts...ral Democrats.// The figures from a local s...ters of Primary Care Trusts have received much les...ervices provided by it, such as sexual health and ...
Other Medicine News:Health News:Transplanted Pig Cells in Human Produce Insulin 2Health News:Transplanted Pig Cells in Human Produce Insulin 3Health News:Breast Cancer and Bra Wearing: Possibly Linked 2Health News:Sultans of Suntans Warned 2Health News:Vaccine Helps Reduce Frequent Ear Infections 2
(Date:11/29/2009)..., CHICAGO, Nov. 29 This year at th...entific Assembly and Annual Meeting, FUJIFILM Medi...e advanced visualization space with the introducti...s core strength in image processing by now offerin...eneral radiographic and cardiovascular application...
(Date:11/27/2009)..., SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCall...stems, Inc. (NYSE: VAR ), a premier supplier of ..., will exhibit its full range of detectors at the ... 29 - December 3, 2009. Varian will also be exhib...s as well as specialized cancer treatment technolo...
(Date:11/25/2009)..., CANOGA PARK, Calif., Nov. 25 P...ace rankings in the American Academy of Family Phy...009 EHR User Satisfaction Survey for improving med...gement, all critical for new ARRA Stimulus legisla...ng their EMR had a positive effect in determining ...
Breaking Medicine Technology:FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 1URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 3Northwest Biotherapeutics Announces Plans to De list From AIM and Consolidate its Stock Market Listing in U S 13177 1Northwest Biotherapeutics Announces Plans to De list From AIM and Consolidate its Stock Market Listing in U S 13177 2Northwest Biotherapeutics Announces Plans to De list From AIM and Consolidate its Stock Market Listing in U S 13177 3Emphysema severity directly linked to coal dust exposure 52621 1Emphysema severity directly linked to coal dust exposure 52621 2Emphysema severity directly linked to coal dust exposure 52621 3
...cin Studies Presented at ECCMID/ICC, MUNICH, Germa...eutics today announced results from two studies sh...bacterial growth in vitro,when tested with a commo...onstrating the activity of oritavancin against S.,...cin, a novel,lipoglycopeptide antibiotic, is Targa...
...ys Show rBChE Suppresses Amyloid Plaque,Formation ...., a leading,biodefense company specializing in th...ntermeasures against chemical and,biological terro...binant butyrylcholinesterase (rBChE) research prog...al Conference on,Alzheimer,s and Parkinson,s Disea...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6
CenterPointLock Non-Sterile Drainable Kits
CenterPointLock Pre-sized Convex Flextend Skin Barrier
CenterPointLock Large Drainable Pouch
CenterPointLock Drainable Pouch, Beige
Medicine Products: